Cash from Operations (TTM) Chart

View Cash from Operations (TTM) for NEVIF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Operations (TTM) Chart
Start Trial

Historical Cash from Operations (TTM) Data

View and export this data back to 2017. Start Trial.
Date Value
November 30, 2025 0.0448M
August 31, 2025 -0.0627M
May 31, 2025 0.0075M
February 28, 2025 0.0118M
November 30, 2024 -0.0896M
August 31, 2024 -0.1122M
May 31, 2024 -0.2939M
February 29, 2024 -0.3438M
November 30, 2023 -0.2859M
August 31, 2023 -0.2232M
May 31, 2023 -0.1413M
February 28, 2023 -0.1369M
November 30, 2022 -0.1145M
August 31, 2022 -0.164M
May 31, 2022 -0.2503M
February 28, 2022 -0.3884M
November 30, 2021 -0.4905M
Date Value
August 31, 2021 -0.5048M
May 31, 2021 -0.5439M
February 28, 2021 -0.5172M
November 30, 2020 -0.6435M
August 31, 2020 -0.9675M
May 31, 2020 -1.306M
February 29, 2020 -1.802M
November 30, 2019 -2.450M
August 31, 2019 -2.543M
May 31, 2019 -2.509M
February 28, 2019 -2.339M
November 30, 2018 -1.504M
August 31, 2018 -1.266M
May 31, 2018 -1.202M
February 28, 2018 -0.9523M
November 30, 2017 -1.112M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (TTM) Range, Past 5 Years

View Cash from Operations (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (TTM) Benchmarks

View Cash from Operations (TTM) Benchmarks
Start Trial
Medifast, Inc. 8.792M
Integrated BioPharma, Inc. 3.026M
BioForce Nanosciences Holdings, Inc. -0.0419M
Skinvisible, Inc. 0.0038M
Skinhealth Systems, Inc. 21.96M